FDA complete response letter

Dupixent Fails to Win FDA Approval for Hives Disorder, Needs More Data

Regeneron and Sanofi have faced an unexpected hurdle in their pursuit of regulatory approval for Dupixent, a monoclonal antibody aimed ...